GlaxoSmithKline (GSK)
_cb-d06b44e9ebf49680492dff6f01008db9-w-640.jpg "Expansion")
Thermo Fisher Scientific expands API manufacturing capabilities
Thermo Fisher Scientific will expand its API manufacturing capabilities at its site in Cork, the company has announced. Read more
How GSK used AR to design a new manufacturing facility
How GSK has embraced a new Augmented Reality (AR) app from BakerHicks to validate the design of a new Aseptic Manufacturing Facility at Barnard Castle. Read more
_cb-09eb015ee4bce141f22d878b31cacef1-w-640.jpg "Genomics")
UK launches world's largest genome project
The UK is to lead a £200 million genomics project in collaboration with four pharmaceutical companies in what’s being described as one of most ambitious programmes ever undertaken. Read more
_cb-2c10dbf88e90d86dc37971842971289e-w-640.jpg "CRISPR")
GSK & University of California to accelerate drug discovery through new CRISPR lab
Major pharma company GSK has announced a five-year collaboration with the University of California to establish a new laboratory which will use CRISPR technologies to help accelerate the discovery of new medicines. Read more
Thermo Fisher to acquire GSK site for complex APIs
Biotechnology company Thermo Fisher has announced that it is to acquire a drug substance manufacturing site from UK pharma player GlaxoSmithKline. Read more
_cb-5043710579e17ea836d1b5026872d684-w-640.jpg "Collaboration")
CPI collaborates with GSK & AstraZeneca on wet granulation project
The Centre for Process Innovation has announced a collaboration with major pharma players GSK and AstraZeneca to create a continuous wet granulation manufacturing facility for oral solid dosage pharmaceuticals. Read more
GSK & Pfizer to merge consumer healthcare lines
GSK has announced it will merge its consumer healthcare business with Pfizer, in a major shake-up of the company. Read more
_cb-35e535871a4cec1e33954158b0195417-w-640.jpg "cancer")
GSK announces major acquisition to bolster oncology pipeline
Pharmaceutical giant GSK has announced a major acquisition of the biotech company Tesaro to help bolster its oncology pipeline. Read more
Q&A: Challenges of aseptic manufacturing with BakerHicks
EPM speaks to BakerHicks about the challenges in building a state-of-the-art aseptic manufacturing facility. Read more
GSK signs up to recruitment system to drive diversity in student and graduate talent
It has been revealed that GlaxoSmithKline (GSK) — a global science-led healthcare company — has signed up to the Contextual Recruitment System (CRS) run by diversity recruitment specialist, Rare, to gain a more diverse range of talent. Read more
AL hutluht / Shutterstock.com
Black-tie dinner with Trump and May includes big pharma CEOs, reports FT
A black-tie dinner has been arranged for UK business leaders — including big pharma CEOs — and the US president, Donald Trump, to be hosted by the prime minister, Theresa May, according to an article published in the Financial Times (FT). Read more
GSK to host the Medicines Manufacturing Industry Partnership conference
GlaxoSmithKline (GSK) is set to open the doors of its site in Stevenage this week to host the Medicines Manufacturing Industry Partnership (MMIP) annual conference, taking place on Thursday 7 June. Read more
GSK & Orchard Therapeutics sign strategic agreement
A strategic agreement has been signed by GlaxoSmithKline (GSK) and Orchard Therapeutics, involving the transfer of GSK’s portfolio of approved and investigational rare disease gene therapies to Orchard. Read more
Novartis sells consumer healthcare joint venture to GSK
Healthcare solutions provider, Novartis, has entered into an agreement with GlaxoSmithKline to divest its 36.5% stake in its consumer healthcare joint venture for $13 billion. Read more
Three specific lots of asthma inhalers recalled due to manufacturing issue
A patient and a pharmacy level drug alert recall has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for three specific lots of asthma inhalers as they may not deliver the full number doses Read more
GSK welcomes Life Sciences Sector Deal with £40 million investment
Science-led global healthcare company, GlaxoSmithKline (GSK) has welcomed the UK government’s announcement of the Life Sciences Sector Deal, by announcing £40 million investment in genomic research. Read more
Deal struck to integrate breath analysis platform into GSK’s danirixin clinical trial
Diagnostics company, Owlstone Medical, has announced that GlaxoSmithKline (GSK) will incorporate its Breath Biopsy platform into the clinical development programme of danirixin — a novel GSK pipeline drug candidate for respiratory disease. Read more
The top five tweets: From the EMA to the Bionow awards — what did EPM readers like this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
GSK’s treatment for COPD is granted marketing authorisation
GlaxoSmithKline (GSK) has announced that its once-daily single inhaler triple therapy, Trelegy Ellipta, for the treatment of chronic obstructive pulmonary disease (COPD) has been granted marketing authorisation by the European Commission. Read more
GSK therapy for multiple myeloma receives breakthrough therapy designation
The Food and Drug Administration (FDA) has granted breakthrough therapy designation to GlaxoSmithKline (GSK) for its investigational B-cell mutation agent (BCMA) monoclonal antibody-drug conjugate, for relapsed and refractory multiple myeloma Read more
